Search results

197 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Norman E. Sharpless, MD, appointed the Wellcome Distinguished Professor in Cancer Research
Chapel Hill, NC – Norman E. “Ned” Sharpless, MD, professor of medicine and genetics and Associate Director for Translational Research at UNC Lineberger Comprehensive Cancer Center has been appointed the Wellcome Distinguished Professor in Cancer Research. The professorship was established by the School of Medicine in 1988 with gifts from the Burroughs Wellcome Fund and the William A. Smith Trust of Wadesboro, NC. The gifts were supplemented by the state of North Carolina the Distinguished Professors Endowment Trust Fund to create the endowed professorship.
Located in News / 2012 News
Tobacco companies, convenience stores form 'deadly alliance' to entice kids to smoke, report says
Tobacco companies have enlisted convenience stores as their most important partners in marketing tobacco products and fighting policies that reduce tobacco use, according to a report released today by leading public health organizations, including The University of North Carolina Gillings School of Global Public Health.
Located in News / 2012 News
Cancer Rumors: What Are They and How They May Help People Cope, Make Sense of Diagnosis
What are cancer rumors and why do people share them?
Located in News / 2012 News
UNC’s Myron Cohen and Terry Magnuson elected to Institute of Medicine
Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Located in News / 2012 News
Study recommends national standards for tobacco use treatment
National Cancer Institute-designated cancer centers should lead the way
Located in News / 2012 News
North Carolina-based genetic resources fuel big scientific progress
Chapel Hill, NC – A series of 15 scientific papers published this week in the journals of the Genetics Society of America (Genetics and G3: Genes|Genomes|Genetics) put North Carolina at the epicenter of a scientific resource called the Collaborative Cross – a “library” of genetic diversity that scientists believe can help fast-track important discoveries about genetics and disease into new discoveries, tests, and treatments that impact human health.
Located in News / 2012 News
Caregiver Conversations: support for caregivers
Look at a typical directory of cancer support groups and you’ll find listings for cancer types, survivorship, and coping. But not too many lists include groups for caregivers.
Located in News / 2012 News
Dr. Lisa Carey authors editorial on neoadjuvant trials for breast cancer
Lisa Carey, MD, authored an editorial, titled “Neoadjuvant Trials of Human Epidermal Growth Factor Receptor 2 Targeting: How Many Drugs Do We Need?”
Located in News / 2012 News
Latest in treatment for Hodgkin Lymphoma, Park comments at annual ASH meeting
As part of Patient Power® coverage of the annual meeting of the American Society of Hematology (ASH), UNC Lineberger member Steven Park, MD, talks about the latest in treatment for Hodgkin Lymphoma.
Located in News / 2012 News
Stem cells poised to self-destruct for the good of the embryo
Embryonic stem cells are primed to kill themselves if damage to their DNA makes them a threat to the developing embryo. UNC researchers reveal how they do it.
Located in News / 2012 News